AANP SmartBrief Latest Industry News

Latest News

Takeda, Amylin to co-develop obesity drugs

Yahoo! | 21 minutes ago

TOKYO (Reuters) ? Japan's Takeda Pharmaceutical and U.S. Amylin Pharmaceuticals said on Monday they will co-develop and commercialize drugs to treat obesity, including two Amylin drugs in mid-stage trials.... (more)

CardioNet reports 3Q loss as it restructures

Yahoo! | 1 hour 24 minutes ago

CONSHOHOCKEN, Pa. ? Wireless heart-monitoring device maker CardioNet Inc. fell to a loss in the third quarter, as it had ramped up marketing spending after Medicare lowered reimbursement rates on the company's products.... (more)

Elan, Biogen change Tysabri label due to PML risk

Forbes | 3 hours 27 minutes ago

DUBLIN, Nov 7 (Reuters) - Ireland's Elan and U.S. drugmaker Biogen Idec have amended the label of their multiple sclerosis drug Tysabri to reflect the increased risk of contracting a potentially deadly brain infection, Elan said in a statement on Saturday.... (more)

Danish drugmaker closing Brooklyn Park facility

Star Tribune (Minneapolis-St. Paul, Minn.) | 3 hours 33 minutes ago

Danish drugmaker Genmab is closing its Brooklyn Park plant as part of money-saving efforts, putting 130 people out of work.... (more)

1 2 3 4 5 6 7 8 9 ... Next >

829 Stories | RSS Feed

Sign up for AANP SmartBrief

Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more